These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7694161)

  • 1. Screening for prostate cancer utilizing the prostate-specific antigen (PSA).
    Halperin EC
    N C Med J; 1993 Sep; 54(9):443-6. PubMed ID: 7694161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum prostate specific antigen for the early detection of prostate cancer in outpatients of internal medicine].
    Otani T; Hayashi Y; Ikuno Y; Hirao Y; Ozono S; Okajima E
    Hinyokika Kiyo; 1996 Sep; 42(9):645-9. PubMed ID: 8918662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical inquiries. Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?
    Fisher M; Beck E
    J Fam Pract; 2002 Feb; 51(2):113. PubMed ID: 11978206
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
    Beemsterboer PM; de Koning HJ; Kranse R; Trienekens PH; van der Maas PJ; Schröder FH
    J Urol; 2000 Oct; 164(4):1216-20. PubMed ID: 10992369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.
    Blijenberg BG; Bangma CH; Kranse R; Eman I; Schröder FH
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):111-4. PubMed ID: 9056753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prostate-specific antigen screening on the natural history of prostate cancer.
    Rosen MA
    Urology; 1995 Dec; 46(6):757-68. PubMed ID: 7502411
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer: the role of prostate-specific antigen.
    Ferrer RL
    Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of serum free prostate specific antigen in the screening of prostate cancer.
    Higashihara E; Nutahara K; Kojima M; Okegawa T; Miura I; Miyata A; Kato M; Sugisaki H; Tomaru T
    J Urol; 1996 Dec; 156(6):1964-8. PubMed ID: 8911366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mass screening for prostate cancer in Nagano].
    Ishizuka O; Satoh T; Kobayashi S; Nishizawa O
    Hinyokika Kiyo; 2001 Nov; 47(11):769-72. PubMed ID: 11771167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer. When to offer screening in the primary care setting.
    Gambert SR
    Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of prostate-specific antigen as a screening test for prostate cancer.
    Dorr VJ; Williamson SK; Stephens RL
    Arch Intern Med; 1993 Nov; 153(22):2529-37. PubMed ID: 7694555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.
    Ito K; Kubota Y; Yamamoto T; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Cancer; 2001 Feb; 91(4):744-51. PubMed ID: 11241242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported prostate cancer screening in Austria.
    Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
    J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related reference intervals for free and total prostate-specific antigen in a Singaporean population.
    Saw S; Aw TC
    Pathology; 2000 Nov; 32(4):245-9. PubMed ID: 11186419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.